| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Primary Health Care | 36 | 2025 | 362 | 6.240 |
Why?
|
| Manitoba | 47 | 2025 | 50 | 3.360 |
Why?
|
| Canada | 43 | 2025 | 157 | 2.900 |
Why?
|
| Chronic Disease | 8 | 2021 | 541 | 2.000 |
Why?
|
| Family Practice | 8 | 2025 | 57 | 1.880 |
Why?
|
| Health Services, Indigenous | 3 | 2021 | 33 | 1.830 |
Why?
|
| Healthcare Disparities | 8 | 2025 | 573 | 1.800 |
Why?
|
| Mental Disorders | 9 | 2025 | 377 | 1.790 |
Why?
|
| Gonorrhea | 6 | 2011 | 24 | 1.650 |
Why?
|
| Physicians, Family | 9 | 2025 | 28 | 1.630 |
Why?
|
| Humans | 145 | 2025 | 42163 | 1.630 |
Why?
|
| Electronic Health Records | 6 | 2025 | 99 | 1.540 |
Why?
|
| Indians, North American | 3 | 2019 | 179 | 1.320 |
Why?
|
| Income | 6 | 2023 | 160 | 1.300 |
Why?
|
| Mental Health Services | 5 | 2025 | 134 | 1.290 |
Why?
|
| Aged | 49 | 2025 | 7982 | 1.250 |
Why?
|
| Male | 86 | 2025 | 22779 | 1.230 |
Why?
|
| Adult | 64 | 2025 | 13458 | 1.220 |
Why?
|
| Middle Aged | 61 | 2025 | 11819 | 1.210 |
Why?
|
| Female | 86 | 2025 | 24018 | 1.200 |
Why?
|
| Research Design | 10 | 2025 | 370 | 1.150 |
Why?
|
| Hospitalization | 9 | 2025 | 482 | 1.100 |
Why?
|
| Population Surveillance | 10 | 2021 | 245 | 1.070 |
Why?
|
| Reimbursement, Incentive | 2 | 2018 | 12 | 1.050 |
Why?
|
| Retrospective Studies | 29 | 2025 | 2485 | 1.050 |
Why?
|
| Leptospirosis | 5 | 2011 | 30 | 0.980 |
Why?
|
| Poverty | 4 | 2025 | 395 | 0.970 |
Why?
|
| Quality of Health Care | 5 | 2022 | 158 | 0.950 |
Why?
|
| Cardiovascular Diseases | 8 | 2025 | 729 | 0.940 |
Why?
|
| Young Adult | 31 | 2025 | 4936 | 0.920 |
Why?
|
| Adolescent | 33 | 2025 | 5950 | 0.890 |
Why?
|
| Ambulatory Care | 3 | 2021 | 81 | 0.870 |
Why?
|
| Child | 22 | 2025 | 3381 | 0.860 |
Why?
|
| Health Services Accessibility | 8 | 2025 | 680 | 0.850 |
Why?
|
| Internship and Residency | 2 | 2024 | 141 | 0.830 |
Why?
|
| Aged, 80 and over | 18 | 2025 | 2803 | 0.820 |
Why?
|
| Analgesics, Opioid | 2 | 2025 | 245 | 0.820 |
Why?
|
| Infant | 16 | 2025 | 1143 | 0.790 |
Why?
|
| Child, Preschool | 18 | 2025 | 1516 | 0.770 |
Why?
|
| Pregnancy Outcome | 2 | 2025 | 92 | 0.760 |
Why?
|
| Prenatal Care | 2 | 2025 | 82 | 0.750 |
Why?
|
| Prescriptions | 1 | 2022 | 20 | 0.750 |
Why?
|
| Bioterrorism | 3 | 2006 | 20 | 0.750 |
Why?
|
| Community Health Services | 4 | 2019 | 207 | 0.740 |
Why?
|
| Psychiatry | 4 | 2025 | 35 | 0.710 |
Why?
|
| Health Status Indicators | 1 | 2021 | 90 | 0.700 |
Why?
|
| Delivery of Health Care | 8 | 2024 | 309 | 0.700 |
Why?
|
| Ontario | 14 | 2025 | 37 | 0.700 |
Why?
|
| Hospitals | 3 | 2023 | 115 | 0.690 |
Why?
|
| Cross-Sectional Studies | 19 | 2025 | 3077 | 0.690 |
Why?
|
| Hawaii | 20 | 2025 | 2004 | 0.690 |
Why?
|
| Review Literature as Topic | 2 | 2017 | 8 | 0.680 |
Why?
|
| Radiosurgery | 3 | 2021 | 56 | 0.680 |
Why?
|
| Health Policy | 3 | 2017 | 184 | 0.660 |
Why?
|
| Chlamydia Infections | 3 | 2009 | 199 | 0.640 |
Why?
|
| Leptospira | 4 | 2011 | 27 | 0.630 |
Why?
|
| Attitude of Health Personnel | 8 | 2020 | 222 | 0.630 |
Why?
|
| Needs Assessment | 5 | 2025 | 180 | 0.610 |
Why?
|
| Cohort Studies | 11 | 2025 | 1729 | 0.600 |
Why?
|
| Attitude to Health | 2 | 2021 | 336 | 0.600 |
Why?
|
| Physicians | 5 | 2015 | 180 | 0.580 |
Why?
|
| Prevalence | 12 | 2025 | 1597 | 0.580 |
Why?
|
| Vaccination | 4 | 2024 | 332 | 0.580 |
Why?
|
| Health Promotion | 5 | 2023 | 691 | 0.580 |
Why?
|
| Fractures, Comminuted | 1 | 2018 | 1 | 0.570 |
Why?
|
| Wrist Joint | 1 | 2018 | 3 | 0.570 |
Why?
|
| Radius Fractures | 1 | 2018 | 4 | 0.570 |
Why?
|
| Infant, Newborn | 8 | 2025 | 960 | 0.560 |
Why?
|
| Radiography | 1 | 2018 | 72 | 0.560 |
Why?
|
| Comorbidity | 7 | 2025 | 725 | 0.560 |
Why?
|
| Publications | 1 | 2017 | 10 | 0.560 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 49 | 0.560 |
Why?
|
| Databases, Factual | 4 | 2021 | 336 | 0.550 |
Why?
|
| Vaccines | 3 | 2023 | 64 | 0.550 |
Why?
|
| Osteoporosis | 1 | 2018 | 48 | 0.540 |
Why?
|
| Holistic Health | 1 | 2017 | 13 | 0.540 |
Why?
|
| Forms and Records Control | 1 | 2017 | 6 | 0.540 |
Why?
|
| Pediatrics | 2 | 2021 | 69 | 0.530 |
Why?
|
| Influenza, Human | 2 | 2013 | 90 | 0.480 |
Why?
|
| Disaster Planning | 2 | 2006 | 58 | 0.470 |
Why?
|
| Cause of Death | 3 | 2020 | 183 | 0.470 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2015 | 164 | 0.470 |
Why?
|
| Referral and Consultation | 2 | 2014 | 141 | 0.470 |
Why?
|
| British Columbia | 10 | 2025 | 19 | 0.470 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2011 | 16 | 0.460 |
Why?
|
| Specialization | 1 | 2014 | 26 | 0.440 |
Why?
|
| Patient Care Team | 4 | 2018 | 57 | 0.440 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2012 | 88 | 0.440 |
Why?
|
| Heart Failure | 6 | 2025 | 298 | 0.430 |
Why?
|
| Qualitative Research | 6 | 2025 | 526 | 0.430 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2016 | 172 | 0.430 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 2 | 0.430 |
Why?
|
| Diabetes Mellitus | 3 | 2014 | 532 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 225 | 0.420 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 22 | 0.420 |
Why?
|
| Coffee | 1 | 2013 | 20 | 0.410 |
Why?
|
| Nurse Practitioners | 2 | 2025 | 23 | 0.410 |
Why?
|
| Socioeconomic Factors | 10 | 2022 | 1221 | 0.410 |
Why?
|
| Preventive Health Services | 2 | 2023 | 65 | 0.400 |
Why?
|
| Hypertension | 4 | 2025 | 823 | 0.400 |
Why?
|
| Health Care Surveys | 5 | 2017 | 152 | 0.400 |
Why?
|
| Mental Health | 2 | 2021 | 363 | 0.400 |
Why?
|
| Health Status Disparities | 5 | 2025 | 705 | 0.400 |
Why?
|
| Carcinoma | 1 | 2014 | 106 | 0.390 |
Why?
|
| Clinical Competence | 3 | 2018 | 154 | 0.390 |
Why?
|
| Health Care Reform | 3 | 2025 | 36 | 0.390 |
Why?
|
| Myocardial Ischemia | 3 | 2019 | 82 | 0.390 |
Why?
|
| Patient-Centered Care | 4 | 2022 | 73 | 0.380 |
Why?
|
| Health Services Research | 3 | 2018 | 161 | 0.380 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 181 | 0.370 |
Why?
|
| Azithromycin | 1 | 2011 | 6 | 0.370 |
Why?
|
| Pneumonia, Viral | 1 | 2013 | 86 | 0.370 |
Why?
|
| Urethritis | 1 | 2011 | 2 | 0.360 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 249 | 0.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 6 | 2015 | 959 | 0.350 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 21 | 0.350 |
Why?
|
| Neisseria meningitidis | 1 | 2011 | 17 | 0.350 |
Why?
|
| Breast Feeding | 3 | 2018 | 123 | 0.350 |
Why?
|
| Health Services Needs and Demand | 3 | 2025 | 154 | 0.340 |
Why?
|
| Child Development | 2 | 2025 | 95 | 0.340 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2025 | 101 | 0.340 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 90 | 0.340 |
Why?
|
| Prostatic Neoplasms | 3 | 2021 | 1068 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 415 | 0.320 |
Why?
|
| Incidence | 9 | 2025 | 1054 | 0.320 |
Why?
|
| Erectile Dysfunction | 1 | 2010 | 39 | 0.310 |
Why?
|
| Stress, Psychological | 1 | 2016 | 641 | 0.310 |
Why?
|
| Syphilis | 1 | 2009 | 24 | 0.310 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2021 | 53 | 0.300 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 121 | 0.300 |
Why?
|
| Registries | 2 | 2017 | 431 | 0.300 |
Why?
|
| Appendicitis | 1 | 2008 | 18 | 0.300 |
Why?
|
| Heterosexuality | 1 | 2009 | 96 | 0.290 |
Why?
|
| Databases as Topic | 2 | 2019 | 24 | 0.290 |
Why?
|
| Brachytherapy | 2 | 2021 | 11 | 0.290 |
Why?
|
| Drug Prescriptions | 2 | 2025 | 60 | 0.290 |
Why?
|
| Child Welfare | 3 | 2017 | 49 | 0.270 |
Why?
|
| Quality of Life | 2 | 2024 | 599 | 0.270 |
Why?
|
| Neoplasms | 2 | 2012 | 1341 | 0.270 |
Why?
|
| Liver Neoplasms | 4 | 2014 | 211 | 0.270 |
Why?
|
| Cooperative Behavior | 2 | 2018 | 250 | 0.250 |
Why?
|
| Dentists | 1 | 2006 | 11 | 0.250 |
Why?
|
| Nurses | 1 | 2006 | 55 | 0.250 |
Why?
|
| Child Abuse | 2 | 2017 | 90 | 0.250 |
Why?
|
| Education, Veterinary | 1 | 2006 | 3 | 0.250 |
Why?
|
| Urban Population | 3 | 2014 | 364 | 0.250 |
Why?
|
| Decision Making | 2 | 2019 | 242 | 0.250 |
Why?
|
| Primary Prevention | 2 | 2017 | 63 | 0.240 |
Why?
|
| Health Status | 4 | 2017 | 432 | 0.240 |
Why?
|
| Risk Assessment | 4 | 2023 | 845 | 0.240 |
Why?
|
| Myocardial Infarction | 3 | 2024 | 242 | 0.240 |
Why?
|
| Regression Analysis | 2 | 2017 | 487 | 0.240 |
Why?
|
| Risk Factors | 9 | 2023 | 3942 | 0.240 |
Why?
|
| Reimbursement Mechanisms | 1 | 2025 | 11 | 0.240 |
Why?
|
| Antihypertensive Agents | 2 | 2025 | 285 | 0.230 |
Why?
|
| Delayed Diagnosis | 1 | 2025 | 33 | 0.230 |
Why?
|
| Health Priorities | 1 | 2025 | 25 | 0.230 |
Why?
|
| Telemedicine | 2 | 2022 | 215 | 0.230 |
Why?
|
| Occupational Exposure | 2 | 2019 | 89 | 0.230 |
Why?
|
| Stroke | 3 | 2025 | 348 | 0.230 |
Why?
|
| Public Housing | 2 | 2015 | 15 | 0.230 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 233 | 0.220 |
Why?
|
| Interprofessional Relations | 3 | 2021 | 56 | 0.220 |
Why?
|
| Regional Health Planning | 1 | 2004 | 14 | 0.220 |
Why?
|
| Coronary Angiography | 3 | 2020 | 97 | 0.220 |
Why?
|
| Journal Impact Factor | 1 | 2024 | 2 | 0.220 |
Why?
|
| Juvenile Delinquency | 1 | 2004 | 44 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2025 | 1051 | 0.210 |
Why?
|
| Health Surveys | 2 | 2009 | 401 | 0.210 |
Why?
|
| Diabetic Angiopathies | 1 | 2023 | 26 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 94 | 0.210 |
Why?
|
| Public Health | 4 | 2017 | 405 | 0.210 |
Why?
|
| Predictive Value of Tests | 2 | 2005 | 438 | 0.210 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 73 | 0.210 |
Why?
|
| Nocturia | 1 | 2023 | 3 | 0.210 |
Why?
|
| Internet | 2 | 2017 | 234 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2025 | 1586 | 0.200 |
Why?
|
| Pregnancy | 5 | 2025 | 1737 | 0.200 |
Why?
|
| Gender Identity | 1 | 2024 | 117 | 0.200 |
Why?
|
| Occult Blood | 3 | 2012 | 32 | 0.200 |
Why?
|
| Educational Status | 2 | 2015 | 335 | 0.200 |
Why?
|
| Nova Scotia | 4 | 2025 | 7 | 0.200 |
Why?
|
| Prisoners | 1 | 2004 | 95 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 454 | 0.190 |
Why?
|
| Social Class | 2 | 2014 | 286 | 0.190 |
Why?
|
| Cardiology | 1 | 2022 | 19 | 0.180 |
Why?
|
| Emergency Service, Hospital | 2 | 2025 | 268 | 0.180 |
Why?
|
| Health Care Costs | 2 | 2020 | 89 | 0.180 |
Why?
|
| Morphine | 1 | 2022 | 68 | 0.180 |
Why?
|
| Residence Characteristics | 2 | 2015 | 359 | 0.180 |
Why?
|
| Demography | 1 | 2022 | 195 | 0.180 |
Why?
|
| Algorithms | 2 | 2015 | 508 | 0.180 |
Why?
|
| Age Distribution | 5 | 2021 | 249 | 0.170 |
Why?
|
| Health Resources | 1 | 2021 | 37 | 0.170 |
Why?
|
| Hypospadias | 1 | 2020 | 3 | 0.170 |
Why?
|
| Patient Care Management | 1 | 2020 | 5 | 0.170 |
Why?
|
| Disease Outbreaks | 3 | 2011 | 169 | 0.170 |
Why?
|
| Atrial Flutter | 1 | 2020 | 7 | 0.170 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 5 | 0.170 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2020 | 9 | 0.160 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2020 | 33 | 0.160 |
Why?
|
| Community Health Planning | 1 | 2020 | 38 | 0.160 |
Why?
|
| Cholesterol | 3 | 2020 | 230 | 0.160 |
Why?
|
| Lipids | 2 | 2022 | 256 | 0.160 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2019 | 6 | 0.160 |
Why?
|
| Linear Models | 2 | 2018 | 311 | 0.160 |
Why?
|
| Occupational Health | 1 | 2019 | 30 | 0.160 |
Why?
|
| Education, Distance | 1 | 2020 | 46 | 0.160 |
Why?
|
| Office Visits | 3 | 2021 | 28 | 0.160 |
Why?
|
| Colorectal Neoplasms | 3 | 2012 | 502 | 0.160 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2019 | 2 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 54 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 78 | 0.150 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 12 | 0.150 |
Why?
|
| Health Personnel | 2 | 2018 | 262 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 34 | 0.150 |
Why?
|
| Program Evaluation | 2 | 2017 | 358 | 0.150 |
Why?
|
| Pesticides | 1 | 2019 | 59 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 164 | 0.150 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 77 | 0.150 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 2 | 2012 | 7 | 0.150 |
Why?
|
| Continuity of Patient Care | 2 | 2022 | 118 | 0.140 |
Why?
|
| Israel | 1 | 2018 | 20 | 0.140 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 36 | 0.140 |
Why?
|
| Quality Control | 1 | 2017 | 41 | 0.140 |
Why?
|
| Forecasting | 2 | 2023 | 136 | 0.140 |
Why?
|
| Geriatrics | 1 | 2018 | 67 | 0.140 |
Why?
|
| Postnatal Care | 1 | 2017 | 16 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2017 | 47 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 40 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2018 | 95 | 0.140 |
Why?
|
| HIV Infections | 2 | 2025 | 2535 | 0.140 |
Why?
|
| Needle-Exchange Programs | 1 | 2017 | 12 | 0.140 |
Why?
|
| Immunization | 1 | 2017 | 93 | 0.140 |
Why?
|
| Immune System Diseases | 1 | 2017 | 21 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 547 | 0.130 |
Why?
|
| House Calls | 1 | 2017 | 8 | 0.130 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 48 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 174 | 0.130 |
Why?
|
| Respiratory Tract Diseases | 2 | 2014 | 30 | 0.130 |
Why?
|
| Family Therapy | 1 | 2017 | 22 | 0.130 |
Why?
|
| Computers | 1 | 2017 | 35 | 0.130 |
Why?
|
| Logistic Models | 5 | 2024 | 1001 | 0.130 |
Why?
|
| Adolescent Health Services | 1 | 2017 | 29 | 0.130 |
Why?
|
| United States | 6 | 2020 | 5072 | 0.130 |
Why?
|
| Child Health Services | 1 | 2017 | 42 | 0.130 |
Why?
|
| Premature Birth | 1 | 2018 | 94 | 0.130 |
Why?
|
| Narration | 1 | 2016 | 37 | 0.130 |
Why?
|
| Whole-Body Irradiation | 2 | 2006 | 9 | 0.120 |
Why?
|
| Stereotaxic Techniques | 2 | 2006 | 19 | 0.120 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2017 | 128 | 0.120 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1058 | 0.120 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 34 | 0.120 |
Why?
|
| Depressive Disorder | 1 | 2017 | 185 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2017 | 138 | 0.120 |
Why?
|
| Disease Notification | 1 | 2015 | 5 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 744 | 0.120 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2015 | 19 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2017 | 587 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2019 | 461 | 0.120 |
Why?
|
| Mothers | 1 | 2017 | 212 | 0.110 |
Why?
|
| Prognosis | 4 | 2023 | 850 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2015 | 25 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 28 | 0.110 |
Why?
|
| Workload | 2 | 2025 | 24 | 0.110 |
Why?
|
| Organization and Administration | 1 | 2014 | 1 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2014 | 9 | 0.110 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 319 | 0.110 |
Why?
|
| Radiodermatitis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Umbilicus | 1 | 2014 | 4 | 0.110 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 24 | 0.110 |
Why?
|
| Exanthema | 1 | 2014 | 12 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2014 | 54 | 0.110 |
Why?
|
| Focus Groups | 3 | 2019 | 398 | 0.110 |
Why?
|
| Time Factors | 4 | 2025 | 1848 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2014 | 143 | 0.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 297 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2024 | 1574 | 0.100 |
Why?
|
| Depression | 2 | 2024 | 837 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 234 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 602 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 289 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2014 | 574 | 0.100 |
Why?
|
| Sexual Behavior | 3 | 2016 | 634 | 0.100 |
Why?
|
| Rural Population | 2 | 2021 | 352 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 55 | 0.090 |
Why?
|
| Access to Information | 1 | 2012 | 14 | 0.090 |
Why?
|
| Hotlines | 1 | 2012 | 16 | 0.090 |
Why?
|
| Cholangiocarcinoma | 1 | 2012 | 7 | 0.090 |
Why?
|
| Population Growth | 1 | 2012 | 8 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 729 | 0.090 |
Why?
|
| Meningococcal Infections | 1 | 2011 | 4 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 96 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 638 | 0.090 |
Why?
|
| Interviews as Topic | 2 | 2025 | 428 | 0.090 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 232 | 0.090 |
Why?
|
| Recreation | 1 | 2011 | 42 | 0.090 |
Why?
|
| Smoking | 1 | 2018 | 1019 | 0.090 |
Why?
|
| Organizational Innovation | 2 | 2024 | 21 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2012 | 190 | 0.080 |
Why?
|
| Lung Neoplasms | 2 | 2006 | 479 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2012 | 225 | 0.080 |
Why?
|
| Asia | 2 | 2020 | 99 | 0.080 |
Why?
|
| Seasons | 1 | 2011 | 133 | 0.080 |
Why?
|
| Professional Autonomy | 1 | 2010 | 4 | 0.080 |
Why?
|
| Nursing Staff | 1 | 2010 | 7 | 0.080 |
Why?
|
| Impotence, Vasculogenic | 1 | 2010 | 13 | 0.080 |
Why?
|
| Carbolines | 1 | 2010 | 17 | 0.080 |
Why?
|
| Nurse's Role | 1 | 2010 | 35 | 0.080 |
Why?
|
| Triazines | 1 | 2010 | 25 | 0.080 |
Why?
|
| Purines | 1 | 2010 | 40 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 35 | 0.080 |
Why?
|
| Sulfones | 1 | 2010 | 47 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 158 | 0.080 |
Why?
|
| Survival Rate | 3 | 2018 | 353 | 0.080 |
Why?
|
| Micronesia | 1 | 2009 | 87 | 0.080 |
Why?
|
| Electrocardiography | 2 | 2020 | 184 | 0.080 |
Why?
|
| Contraception, Postcoital | 1 | 2009 | 8 | 0.080 |
Why?
|
| Student Health Services | 1 | 2009 | 12 | 0.080 |
Why?
|
| Imidazoles | 1 | 2010 | 138 | 0.080 |
Why?
|
| Piperazines | 1 | 2010 | 117 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2006 | 113 | 0.070 |
Why?
|
| Rupture, Spontaneous | 1 | 2008 | 7 | 0.070 |
Why?
|
| Asthma | 1 | 2013 | 410 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 21 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2025 | 1266 | 0.070 |
Why?
|
| Appendectomy | 1 | 2008 | 17 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2023 | 733 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 512 | 0.070 |
Why?
|
| Mortality | 2 | 2020 | 174 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2010 | 386 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 708 | 0.070 |
Why?
|
| Dengue | 1 | 2008 | 100 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 438 | 0.060 |
Why?
|
| Radiation Injuries | 1 | 2006 | 23 | 0.060 |
Why?
|
| Professional Role | 1 | 2006 | 40 | 0.060 |
Why?
|
| Mass Screening | 2 | 2017 | 531 | 0.060 |
Why?
|
| Morbidity | 2 | 2018 | 97 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 48 | 0.060 |
Why?
|
| Advisory Committees | 1 | 2025 | 34 | 0.060 |
Why?
|
| Accidental Falls | 1 | 2025 | 31 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2025 | 153 | 0.060 |
Why?
|
| Aging | 2 | 2020 | 764 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2025 | 21 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2005 | 68 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2025 | 61 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2006 | 366 | 0.060 |
Why?
|
| Triglycerides | 1 | 2005 | 146 | 0.060 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 18 | 0.060 |
Why?
|
| Organizational Case Studies | 1 | 2024 | 31 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 129 | 0.060 |
Why?
|
| Public Opinion | 1 | 2024 | 20 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2005 | 123 | 0.050 |
Why?
|
| Social Perception | 1 | 2005 | 71 | 0.050 |
Why?
|
| Pacific Islands | 1 | 2004 | 121 | 0.050 |
Why?
|
| Bibliometrics | 1 | 2024 | 15 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2004 | 27 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2004 | 15 | 0.050 |
Why?
|
| Censuses | 1 | 2004 | 28 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 24 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 32 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 145 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2004 | 51 | 0.050 |
Why?
|
| Agglutination Tests | 1 | 2003 | 4 | 0.050 |
Why?
|
| Serotyping | 1 | 2003 | 37 | 0.050 |
Why?
|
| Thiazides | 1 | 2023 | 3 | 0.050 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2023 | 7 | 0.050 |
Why?
|
| Information Dissemination | 2 | 2015 | 66 | 0.050 |
Why?
|
| Women's Health | 1 | 2004 | 158 | 0.050 |
Why?
|
| Diuretics | 1 | 2023 | 51 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 33 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2003 | 45 | 0.050 |
Why?
|
| Physician-Nurse Relations | 1 | 2002 | 3 | 0.050 |
Why?
|
| Research Personnel | 1 | 2024 | 191 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2023 | 281 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 236 | 0.050 |
Why?
|
| Age Factors | 2 | 2017 | 1139 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2022 | 35 | 0.050 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 188 | 0.050 |
Why?
|
| Cities | 1 | 2022 | 78 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 471 | 0.040 |
Why?
|
| Geography | 1 | 2021 | 107 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 163 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2021 | 27 | 0.040 |
Why?
|
| Prescription Drugs | 1 | 2021 | 32 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 31 | 0.040 |
Why?
|
| Health Behavior | 1 | 2005 | 568 | 0.040 |
Why?
|
| Risk Management | 1 | 2020 | 8 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 55 | 0.040 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 156 | 0.040 |
Why?
|
| Risk-Taking | 2 | 2017 | 456 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 467 | 0.040 |
Why?
|
| Students | 1 | 2005 | 617 | 0.040 |
Why?
|
| Group Processes | 1 | 2018 | 23 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2018 | 49 | 0.040 |
Why?
|
| Early Detection of Cancer | 2 | 2012 | 428 | 0.030 |
Why?
|
| Needle Sharing | 1 | 2017 | 11 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2017 | 71 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2017 | 74 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 35 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2017 | 73 | 0.030 |
Why?
|
| Physician-Patient Relations | 2 | 2012 | 146 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2016 | 33 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2024 | 825 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2018 | 187 | 0.030 |
Why?
|
| Capitation Fee | 1 | 2016 | 3 | 0.030 |
Why?
|
| Quebec | 1 | 2015 | 4 | 0.030 |
Why?
|
| Fee-for-Service Plans | 1 | 2016 | 21 | 0.030 |
Why?
|
| Professional Competence | 1 | 2015 | 42 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2016 | 44 | 0.030 |
Why?
|
| School Health Services | 1 | 2016 | 89 | 0.030 |
Why?
|
| Hospitals, Rural | 1 | 2014 | 25 | 0.030 |
Why?
|
| Attitude | 1 | 2015 | 108 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2014 | 42 | 0.030 |
Why?
|
| Schools | 1 | 2016 | 283 | 0.030 |
Why?
|
| Models, Economic | 1 | 2013 | 30 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 76 | 0.030 |
Why?
|
| Bronchitis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 176 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 4 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 2012 | 4 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 126 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 1679 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 358 | 0.020 |
Why?
|
| Delegation, Professional | 1 | 2010 | 1 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2010 | 11 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2010 | 16 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2009 | 7 | 0.020 |
Why?
|
| Pregnancy, Unplanned | 1 | 2009 | 29 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 83 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 57 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2008 | 3 | 0.020 |
Why?
|
| Animals | 1 | 2006 | 16695 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2009 | 98 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 136 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 87 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 117 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2009 | 181 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.020 |
Why?
|
| Unsafe Sex | 1 | 2009 | 162 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 456 | 0.020 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2006 | 1 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2006 | 8 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 39 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2006 | 84 | 0.020 |
Why?
|
| Universities | 1 | 2009 | 539 | 0.010 |
Why?
|
| Fasting | 1 | 2005 | 56 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 73 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 99 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 150 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 246 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2004 | 224 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2002 | 117 | 0.010 |
Why?
|
| Health Education | 1 | 2005 | 358 | 0.010 |
Why?
|
| Mammography | 1 | 2002 | 211 | 0.010 |
Why?
|